Do you want to read an article? Please log in or register.
Understanding the developmental pathways pulmonary fibroblasts may follow during alveolar regeneration.
Related content
RECOMMENDED
Pulmonary Fibrosis
Chaotic activation of developmental signalling pathways drives idiopathic pulmonary fibrosis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev.
Froidure A, Marchal-Duval E, Homps-Legrand M, Ghanem M, Justet A, Crestani B, Mailleux A
doi: 10.1183/16000617.0140-2019.Visit the full text of the original publication at err.ersjournals.com
Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach
Lancet Respir Med.
Kumar A, Abdelmalak B, Inoue Y, Culver DA
doi: 10.1016/S2213-
Asthma
TGF-β Upregulated Mitochondria Mass through the SMAD2/3→C/EBPβ→PRMT1 Signal Pathway in Primary Human Lung Fibroblasts
J Immunol.
Sun Q, Fang L, Tang X, Lu S, Tamm M, Stolz D, Roth M
doi: 10.4049/jimmunol.1800782.
COMMENTED
Multicentre observational screening survey for the detection of CTEPH following pulmonary embolism
Eur Respir J.
Coquoz N, Weilenmann D, Stolz D, Popov V, Azzola A, Fellrath JM, Stricker H, Pagnamenta A, Ott S, Ulrich S, Györik S, Pasquier J, Aubert JD
doi: 10.1183/
Invasive haemodynamic evaluation of the pulmonary circulation in pulmonary hypertension
Swiss Med Wkly.
Pagnamenta A, Azzola A, Beghetti M, Lador F, On Behalf Of The Swiss Society Of Pulmonary Hypertension
doi: smw.2017.14445
Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study
PLoS One.
Franzen DP, Nowak A, Haile SR, Mottet D, Bonani M, Dormond O, Kohler M, Krayenbuehl PA, Barbey F
doi: 10.1371/journal.pone.0180437
CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis
Thorax.
Jia G, Chandriani S, Abbas AR, DePianto DJ, N'Diaye EN, Yaylaoglu MB1, Moore HM, Peng I, DeVoss J, Collard HR, Wolters PJ, Egen JG, Arron JR
doi: 10.1136/thoraxjnl-
RECOMMENDED
Emphysema
Additive effect on pulmonary function and disability of intensive pulmonary rehabilitation following bronchoscopy lung volume reduction (BLVR) for severe emphysema
Respir Med.
Bianchi L, Bezzi M, Berlendis M, Marino S, Montini A, Paneroni M, Novali M, Steinhilber G, Vitacca M
doi: 10.1016/j.rmed.2018.09.006.
RECOMMENDED
Respiratory Tract Infection
Swiss Recommendations for the Follow-Up and Treatment of Pulmonary Long COVID
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respiration
Funke-Chambour M, Bridevaux PO, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C, Swiss COVID Lung Study Group and the Swiss Society of Pulmonology.
doi: 10.1159/000517255